Ex vivo γH2AX assay for tumor radiosensitivity in primary prostate cancer patients and correlation with clinical parameters.
Marinescu IM, Rogg M, Spohn S, von Büren M, Kamps M, Jilg CA, Fountzila E, Papadopoulou K, Ceci L, Bettermann A, Ruf J, Benndorf M, Adebahr S, Zips D, Grosu AL, Schell C, Zamboglou C.
Marinescu IM, et al. Among authors: zips d.
Radiat Oncol. 2022 Oct 5;17(1):163. doi: 10.1186/s13014-022-02131-1.
Radiat Oncol. 2022.
PMID: 36199143
Free PMC article.